Trupanion has launched its IPO after pricing its 7.125 million shares at $10 per share. The stock began trading Friday on the NYSE under the ticker symbol “TRUP.” RBC Capital Markets, Barclays and Stifel are the lead underwriters. Based in Seattle, Trupanion is a pet insurance provider. It is backed by Maveron and Highland Capital Partners.
SEATTLE – July 17, 2014 —Trupanion, Inc. announced today the pricing of its initial public offering of 7,125,000 shares of common stock at a price to the public of $10.00 per share. The shares are expected to begin trading on the New York Stock Exchange on July 18, 2014 under the symbol “TRUP.” In addition, the underwriters have been granted a 30-day option to purchase up to an additional 1,068,750 shares of common stock.
RBC Capital Markets, Barclays and Stifel are acting as joint book-running managers for the offering. Canaccord Genuity and Cowen and Company are acting as co-managers for the offering.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission and was declared effective on July 17, 2014. The offering is being made only by means of a prospectus. When available, copies of the final prospectus related to the offering may be obtained from RBC Capital Markets, Attention: Equity Syndicate, 3 World Financial Center, 200 Vesey Street, 8th Floor, New York, NY 10281, or by telephone at 877-822-4089; Barclays, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at 888-603-5847 or by email at [email protected]; or Stifel, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, or by telephone at 415-364-2720 or by email at [email protected]
Take your pick!
- Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
- VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.